Global Custom Market Research Reports Provider Company

phone

Advicenne SA (ADVIC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 18
  • Category: Pharmaceuticals
  • Country: France
Summary

Advicenne SA (Advicenne) is a developer of pediatric medicines. The companys product portfolio includes ADV6209, a liquid formulation of a benzodiazepine for moderate sedation and anesthetic premedication; ADV7103, a formulation in the form of micro-tablets for renal tubulopathies. It offers its products for the treatment of neurological diseases and renal disorders in children. Advicenne also provides products for the treatment epilepsy, anesthesia and dystonia. The company provides clinical research services by using statistical tools, approaches of meta-analysis and data modeling and simulation. It works in partnership with other pharmaceutical companies. The company operates through its offices in Nimes, Montbonnot and Paris, France. Advicenne is headquartered in Nimes, France.

Advicenne SA (ADVIC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advicenne SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Advicenne SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Advicenne SA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Advicenne Pharma Raises USD17 Million in Financing Round 10
Advicenne Pharma To Raise Funds Through Venture Financing 11
Licensing Agreements 12
Advicenne Pharma Enters into Licensing Agreement with Desitin 12
Equity Offering 13
Advicenne Pharma Raises USD32 Million in IPO of Shares 13
Asset Transactions 14
Primex Pharma Acquires Rights to Oral Pharma Candidate for Pediatric Anesthesiology from Advicenne 14
Advicenne SA - Key Competitors 15
Advicenne SA - Key Employees 16
Advicenne SA - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables

List of Tables
Advicenne SA, Pharmaceuticals & Healthcare, Key Facts 2
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advicenne SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advicenne SA, Deals By Therapy Area, 2012 to YTD 2018 8
Advicenne SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Advicenne Pharma Raises USD17 Million in Financing Round 10
Advicenne Pharma To Raise Funds Through Venture Financing 11
Advicenne Pharma Enters into Licensing Agreement with Desitin 12
Advicenne Pharma Raises USD32 Million in IPO of Shares 13
Primex Pharma Acquires Rights to Oral Pharma Candidate for Pediatric Anesthesiology from Advicenne 14
Advicenne SA, Key Competitors 15
Advicenne SA, Key Employees 16
Advicenne SA, Other Locations 17

List Of Figures

List of Figures
Advicenne SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advicenne SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Advicenne SA (Advicenne) is a developer of pediatric medicines. The companys product portfolio includes ADV6209, a liquid formulation of a benzodiazepine for moderate sedation and anesthetic premedication; ADV7103, a formulation

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports